Please assess the completion status of the following clinical trial:

Trial Title: Comparing Palliative Radiotherapy With or Without Carboplatin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with locally advanced or metastatic bronchial or head and neck cancer~* Patient require palliative radiotherapy~* Age ≥ 18 years~* PS ≤ 2~* Obtaining the signed written consent of the patient~* Patient affiliated to a social security scheme~Exclusion Criteria:~* Other chemotherapy or targeted therapy~* Prior radiation~* Patients with thrombopenia \< 100 000~* Patients with neutropenia \< 2000~* Patients with renal clearance \< 20 mL/min~* Known hypersensitivity to platinum salt~* Treatment with phenytoin or fosphenytoin~* In previous three months, a vaccination against yellow fever, live vaccin or live attenuated vaccine~* Unchecked diabetes~* hemorrhagic tumor~* Refusal of participation or inability to issue informed consent~* Person deprived of liberty or adult under guardianship~* Minor patients, pregnant or lactating women~* Participation in other interventional study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- irradiation + carboplatin (Type: EXPERIMENTAL): Radiotherapy in 30 Gy en 10 fractions de 3 Gy. The overall duration to irradiation is 2 weeks Carboplatin. :10 injections 1h prior irradiation
- irradiation + placebo (Type: PLACEBO_COMPARATOR): Radiotherapy in 30 Gy en 10 fractions de 3 Gy. The overall duration to irradiation is 2 weeks Placebo :10 injections 1h prior irradiation

Based on this trial design, predict the completion outcome and termination type (if applicable).